The purpose of the investment is to amplify its skills and jointly craft groundbreaking solutions.
Indian multinational technology company Infosys announced on Friday that it is investing Rs 8 crore (approximately USD 1.0 million) in the healthcare and life sciences startup 4baseCare. The investment is part of its Infosys Innovation Fund. In its regulatory filing, Infosys stated that the population specific datasets generated by the startup is powered by tech-driven AI and Analytics, emphasizing that it has potential to improve cancer diagnosis, treatment, etc.
“4baseCare provides unique precision oncology solutions leveraging diverse genomic and clinical data.” “The population-specific datasets generated by them powered by tech-driven AI and analytics solutions have immense potential to improve cancer diagnosis, treatment, drug discovery and development across Healthcare and Life Sciences ecosystem, improving lives,” Infosys said in its regulatory filing.
Read More: Petrol, Diesel Fresh Prices Announced: Check Rates In Your City On December 15
The Infosys Innovation Fund is taking significant strides, eyeing cooperation with AI and DeepTech start-ups such as 4baseCare. The purpose of the investment is to amplify its skills and jointly craft groundbreaking solutions. According to official reports, these novel solutions rooted in innovation will help Infosys’ clients navigate their business transformations with much greater ease.
Read More: Today Gold Rate 15-12-2024: Check latest prices in your city
“A minority holding, not exceeding 20% of the outstanding share capital of the company,” Infosys further said in the filling.
4baseCare is passionately working towards developing cutting-edge personalized cancer treatments. By cleverly leveraging high-tech genomics and the next-gen digital health tech, they aim to craft cancer therapies specifically designed for each patient.
